CurifyLabs (Series A)
Funding Details
- Awarder
- RSS - tech.eu
- Date Award
- May 27, 2025
- Vertical
- Healthtech
- Funding URL
- View Funding Page
- Funding Amount:
- $6,700,000
Company Info
- Traction
- CurifyLabs has raised a total of €17.6 million in funding and is positioned for substantial growth in the US market, where the majority of compounding manufacturing occurs.
- Founders
- Charlotta Topelius, Niklas Sandler Topelius
- Company Description
- CurifyLabs aims to disrupt the outdated, error-prone compounding process that serves millions, including children and cancer patients who can’t take standard medications. The company has developed a solution to automate the manufacturing of compounded medicine, making the process four times faster and enabling limitless dosing flexibility.
- Market
- Pharmaceutical Manufacturing
- Location
- Finland
- Coinvestors
- Springvest, Business Finland